Joanne C. Alfred
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanne C. Alfred has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Alexa Rodriguez
Department of Pediatrics, School of Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
1 shared publicationCheryl Yang
Department of Pediatrics, Division of Pediatric Emergency Medicine University of Utah Salt Lake City UT USA
1 shared publicationCornelia Roata
Department of Pathology and Laboratory Medicine School of Medicine, University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
1 shared publication- Erica Marie Sparkenbaugh
University of North Carolina at Chapel Hill
1 shared publication - Jeremy R. Wang
University of North Carolina at Chapel Hill
1 shared publication Jessica Buddenbaum
Department of Pediatrics, School of Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
1 shared publication
Latest Publications
- Open Access
- 4 September 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (4)
Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
- 4 September 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (4)
Open AccessPlatelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
- 25 July 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (9) , e70584
Rapid Molecular Diagnostics Enables Individualized Frontline Treatment of CBFA2T3::GLIS2 ‐Rearranged Acute Myeloid Leukemia
In this paper, we discuss how Nanopore whole genome sequencing (WGS) was utilized for rapid genomic identification of CBFA2T3::GLIS2‐ rearranged acute myeloid leukemia (AML) for two pediatric patients. Patients with CBFA2T3::GLIS2 AML have a 27% 5‐year event‐free survival. Prior case reports demonstrated that recurrent CBFA2T3::GLIS2 AML has a favorable treatment response to azacitidine, venetoclax, and gemtuzumab. Nanopore WGS enabled early recognition of the CBFA2T3::GLIS2 rearrangement, providing the opportunity to choose alternative therapies upfront with azacitidine, venetoclax, and gemtuzumab. We discuss our patients’ status and the implications of a rapid molecular diagnostic method like Nanopore WGS. Trial Registration : Clinicaltrials.gov identifier: NCT06609928
- 25 July 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (9) , e70584
Rapid Molecular Diagnostics Enables Individualized Frontline Treatment of CBFA2T3::GLIS2 ‐Rearranged Acute Myeloid Leukemia
In this paper, we discuss how Nanopore whole genome sequencing (WGS) was utilized for rapid genomic identification of CBFA2T3::GLIS2‐ rearranged acute myeloid leukemia (AML) for two pediatric patients. Patients with CBFA2T3::GLIS2 AML have a 27% 5‐year event‐free survival. Prior case reports demonstrated that recurrent CBFA2T3::GLIS2 AML has a favorable treatment response to azacitidine, venetoclax, and gemtuzumab. Nanopore WGS enabled early recognition of the CBFA2T3::GLIS2 rearrangement, providing the opportunity to choose alternative therapies upfront with azacitidine, venetoclax, and gemtuzumab. We discuss our patients’ status and the implications of a rapid molecular diagnostic method like Nanopore WGS. Trial Registration : Clinicaltrials.gov identifier: NCT06609928
- 19 December 2025
- Published by Wiley in The Clinical Teacher
- Vol. 23 (1) , e70335
The Trusted Senior: How Attendings and Residents Can Co‐Create Success
Growth mindset, the belief that one's abilities are changeable, is a valued attribute in medical education. Developing a growth mindset is also in direct tension with systems that evaluate performance, such as in medical training. The senior resident role is a microcosm of this tension because it is a pivotal transition time from training to attending. A recently updated framework for clinical competency places trusted as the highest goal for trainees, defined as self‐awareness that is bolstered by humility, integrity, and reliability. We provide strategies for both the senior and attending to foster a senior's goal of trusted status. This requires intentional work by both the senior and attending, but we posit that the attending role is paramount in first creating a learning environment that celebrates a growth mindset. The strategies work to promote self‐reflection, active problem solving, and exploration of the gray areas of medical decision making to maximize the learning experience.
- 19 December 2025
- Published by Wiley in The Clinical Teacher
- Vol. 23 (1) , e70335
The Trusted Senior: How Attendings and Residents Can Co‐Create Success
Growth mindset, the belief that one's abilities are changeable, is a valued attribute in medical education. Developing a growth mindset is also in direct tension with systems that evaluate performance, such as in medical training. The senior resident role is a microcosm of this tension because it is a pivotal transition time from training to attending. A recently updated framework for clinical competency places trusted as the highest goal for trainees, defined as self‐awareness that is bolstered by humility, integrity, and reliability. We provide strategies for both the senior and attending to foster a senior's goal of trusted status. This requires intentional work by both the senior and attending, but we posit that the attending role is paramount in first creating a learning environment that celebrates a growth mindset. The strategies work to promote self‐reflection, active problem solving, and exploration of the gray areas of medical decision making to maximize the learning experience.